(PDF) Adverse Event Profiles of Solvent-Based and

Adverse Event Profiles of Solvent-Based and Nanoparticle Albumin-Bound Paclitaxel Formulations Using the Food and Drug Administration Adverse Event Reporting System

SAGE Open Medicine - United Kingdom

doi 10.1177/2050312119836011

Full Text

Open PDF

Abstract

Available in full text

Date

January 1, 2019

Authors

Publisher

SAGE Publications

Related search

A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia

Annals of Pharmacotherapy

Medicine

Pharmacology

2019

English

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System

CPT: Pharmacometrics and Systems Pharmacology

Modeling

Simulation

Cardiovascular Medicine

Pharmacology

Cardiology

2018

English

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database

Drugs - Real World Outcomes

Pharmacology

2018

English

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

English

Assessment of the Real-World Safety Profile of Vedolizumab Using the United States Food and Drug Administration Adverse Event Reporting System

PLoS ONE

Multidisciplinary

2019

English

Analysis of the Association of Administration of Various Glucocorticoids With Development of Acute Pancreatitis Using US Food and Drug Administration Adverse Event Reporting System (FAERS)

Journal of Pharmaceutical Health Care and Sciences

2019

English

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Proceedings for Annual Meeting of The Japanese Pharmacological Society

2020

English

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

English

Seasonal and Geographic Variation in Adverse Event Reporting

Drugs - Real World Outcomes

Pharmacology

2016

English

Amanote Research

Adverse Event Profiles of Solvent-Based and Nanoparticle Albumin-Bound Paclitaxel Formulations Using the Food and Drug Administration Adverse Event Reporting System

SAGE Open Medicine - United Kingdom

doi 10.1177/2050312119836011

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Assessment of the Real-World Safety Profile of Vedolizumab Using the United States Food and Drug Administration Adverse Event Reporting System

Analysis of the Association of Administration of Various Glucocorticoids With Development of Acute Pancreatitis Using US Food and Drug Administration Adverse Event Reporting System (FAERS)

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

Seasonal and Geographic Variation in Adverse Event Reporting